Taken together, the present results suggest that autoantibodies penetrating the BBB from the serum to the brain may act on the mAChR directly and specifically in the CFS brain without altering AChE activity. The gene discussed is ACHE; the disease is myalgic encephalomeyelitis/chronic fatigue syndrome.